Nanomedicine Preclinical Researcher Position In Nano4Rare Project Icmab

Molecular Nanoscience and Organic Materials Department, NANOMOL-BIO group (https://icmab.es/mnom/nanomol-bio); Institut de Ciència de Materials de Barcelona (ICMAB-CSIC).

NANOMOL has extensive experience and recognized excellence in the synthesis, processing, and study of molecular and polymeric materials with chemical, electronic, magnetic, and biomedical properties. We continuously generate new knowledge in our basic and applied research projects on the micro and nanostructure of molecular materials. We offer this knowledge to improve the properties of products manufactured in different sectors, such as chemical, pharmaceutical, and electronic, thus contributing to increase their added value. As a department, we actively participate in the implementation of nanotechnology and sustainable and economically efficient technologies for the preparation of advanced functional molecular materials. NANOMOL is a member of the Biomedical Research Network (CIBER) in the area of Bioengineering, Biomaterials, and Nanomedicine (CIBER-BNN); and is awarded with the TECNIO seal, which is given to Catalan research groups with high innovative and technology transfer capabilities. We belong to the Institute of Materials Science of Barcelona (www.icmab.es), a CSIC research institute. Our facilities are located on the campus of the UAB (Universitat Autònoma de Barcelona).

The candidate will work in the Nano4Rare project (Preclinical development of a nanomedicine candidate for Fabry rare disease treatment to enter clinical phase), funded by the Strategic EIC Transition Challenges program from European Innovation Council.

As a Nanomedicine Preclinical Researcher, you will play a pivotal role in advancing our project towards clinical phase.



#J-18808-Ljbffr